GNCA logo

Genocea Biosciences (GNCA) EBIT

Annual EBIT

-$32.08 M
+$10.26 M+24.23%

December 31, 2021

Summary

Performance

1-Year Change

+24.23%

3-Year Change

-19.73%

5-Year Change

+41.97%

15-Year Change

+41.97%

GNCA EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$12.86 M

3-Year Low

-$32.08 M
GNCA annual earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2021
GNCA previous annual earnings announcement was published on Dec 31, 2021

Next Annual Earnings Report Date

N/A
GNCA next annual earnings announcement has not yet been scheduled

OtherGNCAprofitabilitymetrics:

Annual Revenue

$1.64 M
GNCA annual revenue is $1.64 million

Annual Net Income

-$33.20 M
GNCA annual net profit is -$33.20 million

Annual EBITDA

-$30.52 M
GNCA annual EBITDA is -$30.52 million

Annual EPS

-$0.48
GNCA annual earnings per share is -$0.48

Quarterly EBIT

-$15.75 M
-$2.74 M-21.04%

March 31, 2022

Summary

Performance

3-Month Change

-21.04%

1-Year Change

-34.54%

3-Year Change

-3.16%

5-Year Change

-17.73%

GNCA Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$663.00 K
GNCA quarterly earnings before interest & taxes is currently -2475.11% below its historical high of $663.00 thousand

3-Year Low

-$15.75 M
GNCA quarterly earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
GNCA previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
GNCA next earnings announcement has not yet been scheduled

OtherGNCAprofitabilitymetrics:

Quarterly Revenue

$270.00 K
GNCA quarterly revenue is $270.00 thousand

Quarterly Net Income

-$15.98 M
GNCA quarterly net profit is -$15.98 million

Quarterly EBITDA

-$15.35 M
GNCA quarterly EBITDA is -$15.35 million

Quarterly EPS

-$0.22
GNCA quarterly earnings per share is -$0.22

TTM EBIT

-$36.12 M
-$4.04 M-12.60%

March 31, 2022

Summary

Performance

3-Month Change

-12.6%

1-Year Change

+12.85%

3-Year Change

+4.96%

5-Year Change

+4.96%

GNCA TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$4.52 M

3-Year Low

-$36.12 M
GNCA TTM earnings before interest & taxes is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2022
GNCA previous earnings announcement was published on Mar 31, 2022

Next Quarterly Earnings Report Date

N/A
GNCA next earnings announcement has not yet been scheduled

OtherGNCAprofitabilitymetrics:

TTM Revenue

$1.91 M
GNCA TTM revenue is $1.91 million

TTM Net Income

-$37.19 M
GNCA TTM net profit is -$37.19 million

TTM EBITDA

-$34.54 M
GNCA TTM EBITDA is -$34.54 million

TTM EPS

-$0.66
GNCA TTM earnings per share is -$0.66

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$32.08 M
GNCA annual earnings before interest & taxes is -$32.08 million

Annual Revenue

$1.64 M
GNCA annual revenue is $1.64 million

Annual Cost Of Goods Sold

-
GNCA annual cost of goods sold value is unknown

Annual Operating Expenses

$53.73 M
GNCA annual total operating expenses is $53.73 million

GNCA EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+24.2%-34.5%+12.8%
3 y3 years-19.7%-3.2%+5.0%
5 y5 years+42.0%-17.7%+5.0%

GNCA EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat highat low+21.0%at low+12.6%at low
5 y5-yearat high+32.0%+372.6%at low+12.6%+17.2%
alltimeall time+149.4%+72.3%-2475.1%+4.8%+699.8%+67.4%

Genocea Biosciences EBIT History

DateAnnualQuarterlyTTM
Mar 2022
-
-$15.75 M(+21.0%)
-$36.12 M(+12.6%)
Dec 2021
-$32.08 M(-24.2%)
-$13.01 M(+290.5%)
-$32.08 M(-4.7%)
Sep 2021
-
-$3.33 M(-17.3%)
-$33.67 M(-2.5%)
Jun 2021
-
-$4.03 M(-65.6%)
-$34.52 M(-16.7%)
Mar 2021
-
-$11.70 M(-19.9%)
-$41.44 M(-2.1%)
Dec 2020
-$42.33 M(+11.4%)
-$14.61 M(+249.6%)
-$42.33 M(+14.7%)
Sep 2020
-
-$4.18 M(-61.9%)
-$36.89 M(-8.0%)
Jun 2020
-
-$10.96 M(-13.0%)
-$40.09 M(+13.5%)
Mar 2020
-
-$12.59 M(+37.4%)
-$35.33 M(-7.0%)
Dec 2019
-$38.00 M(+41.9%)
-$9.16 M(+24.2%)
-$38.00 M(+34.9%)
Sep 2019
-
-$7.38 M(+19.1%)
-$28.18 M(-0.7%)
Jun 2019
-
-$6.20 M(-59.4%)
-$28.36 M(+7.6%)
Mar 2019
-
-$15.27 M(-2402.4%)
-$26.37 M(-1.6%)
Dec 2018
-$26.79 M(-51.5%)
$663.00 K(-108.8%)
-$26.79 M(-29.2%)
Sep 2018
-
-$7.57 M(+80.3%)
-$37.84 M(-19.1%)
Jun 2018
-
-$4.20 M(-73.2%)
-$46.77 M(-18.8%)
Mar 2018
-
-$15.69 M(+51.1%)
-$57.58 M(+4.2%)
Dec 2017
-$55.27 M
-$10.38 M(-37.1%)
-$55.27 M(-8.6%)
Sep 2017
-
-$16.50 M(+10.0%)
-$60.48 M(+7.4%)
DateAnnualQuarterlyTTM
Jun 2017
-
-$15.01 M(+12.2%)
-$56.30 M(+8.5%)
Mar 2017
-
-$13.38 M(-14.2%)
-$51.89 M(+8.5%)
Dec 2016
-$47.84 M(+16.1%)
-$15.60 M(+26.5%)
-$47.84 M(+13.3%)
Sep 2016
-
-$12.33 M(+16.4%)
-$42.22 M(+7.3%)
Jun 2016
-
-$10.59 M(+13.7%)
-$39.34 M(+1.5%)
Mar 2016
-
-$9.32 M(-6.6%)
-$38.76 M(-5.9%)
Dec 2015
-$41.20 M(+20.2%)
-$9.98 M(+5.6%)
-$41.20 M(-3.1%)
Sep 2015
-
-$9.45 M(-5.6%)
-$42.53 M(+1.2%)
Jun 2015
-
-$10.01 M(-14.9%)
-$42.04 M(+8.0%)
Mar 2015
-
-$11.77 M(+4.1%)
-$38.94 M(+13.6%)
Dec 2014
-$34.27 M(+68.4%)
-$11.31 M(+26.2%)
-$34.27 M(+17.4%)
Sep 2014
-
-$8.96 M(+29.7%)
-$29.19 M(+16.9%)
Jun 2014
-
-$6.91 M(-2.7%)
-$24.97 M(+9.0%)
Mar 2014
-
-$7.10 M(+14.0%)
-$22.91 M(+12.6%)
Dec 2013
-$20.35 M(+58.2%)
-$6.22 M(+31.5%)
-$20.35 M(+9.2%)
Sep 2013
-
-$4.74 M(-2.4%)
-$18.64 M(+34.1%)
Jun 2013
-
-$4.85 M(+6.9%)
-$13.90 M(+53.6%)
Mar 2013
-
-$4.54 M(+0.5%)
-$9.05 M(+100.5%)
Dec 2012
-$12.86 M(-12.2%)
-$4.52 M
-$4.52 M
Dec 2011
-$14.65 M
-
-

FAQ

  • What is Genocea Biosciences annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Genocea Biosciences?
  • What is Genocea Biosciences annual EBIT year-on-year change?
  • What is Genocea Biosciences quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Genocea Biosciences?
  • What is Genocea Biosciences quarterly EBIT year-on-year change?
  • What is Genocea Biosciences TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Genocea Biosciences?
  • What is Genocea Biosciences TTM EBIT year-on-year change?

What is Genocea Biosciences annual earnings before interest & taxes?

The current annual EBIT of GNCA is -$32.08 M

What is the all time high annual EBIT for Genocea Biosciences?

Genocea Biosciences all-time high annual earnings before interest & taxes is -$12.86 M

What is Genocea Biosciences annual EBIT year-on-year change?

Over the past year, GNCA annual earnings before interest & taxes has changed by +$10.26 M (+24.23%)

What is Genocea Biosciences quarterly earnings before interest & taxes?

The current quarterly EBIT of GNCA is -$15.75 M

What is the all time high quarterly EBIT for Genocea Biosciences?

Genocea Biosciences all-time high quarterly earnings before interest & taxes is $663.00 K

What is Genocea Biosciences quarterly EBIT year-on-year change?

Over the past year, GNCA quarterly earnings before interest & taxes has changed by -$4.04 M (-34.54%)

What is Genocea Biosciences TTM earnings before interest & taxes?

The current TTM EBIT of GNCA is -$36.12 M

What is the all time high TTM EBIT for Genocea Biosciences?

Genocea Biosciences all-time high TTM earnings before interest & taxes is -$4.52 M

What is Genocea Biosciences TTM EBIT year-on-year change?

Over the past year, GNCA TTM earnings before interest & taxes has changed by +$5.33 M (+12.85%)